Exercise Prescription in Children With Hypertrophic Cardiomyopathy (Empower)
Effects of Exercise Prescription on Cardiovascular Health and Quality of Life in Children With Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM) is an inherited cardiac condition that affects the heart muscle of adults and children. Historically, doctors have been cautious about encouraging patients with HCM to exercise, as they were worried it could be unsafe due to the risk of heart problems or emergencies. But recent evidence shows that the risks of exercise for a patient with HCM are far lower than previously thought and exercise has many benefits for a child's general health and mental well-being and is an important part of their social development.
One way to help children with HCM feel confident to exercise is with an individualised exercise 'prescription'. This is where a team of specialist doctors, nurses, and physiotherapists assess patients and advise them on how to exercise safely and effectively. They then provide an exercise plan or 'prescription' individualised to them.
This study aims to establish whether the investigators can deliver an individualised exercise prescription (IEP) service for children with HCM who attend outpatient cardiology. A further aim is to see if children will want to take part and adhere to the IEP.
In this study children aged 10 to 18 years old attending outpatient cardiology clinic at Alder Hey Children's Hospital (AHCH) under screening for HCM will be asked if they wish to take part in the study. Those who wish to take part will have extra appointments at AHCH, during which the investigators will measure their height and weight. They will also have other tests done like blood pressure, a cycle test, sit-to-stand test, measurement of their hamstring flexibility and an ultrasound measure of their thigh muscle.
The participants will be asked to complete a questionnaire about their quality of life. The participants will then be given an individualised exercise plan. In the first month, they will be given a supervised exercise session and asked to record their activity levels in an exercise log.
The participants will have either a monthly telephone call or a face-to-face visit to see how they are getting on. After 6 months, all the initial tests will be repeated. The investigators will look at the data to see if the exercise prescription was helpful, if children could stick to it and if there have been improvements in their fitness and quality of life. Finally, the investigators will see them again six months later to see if the IEP programme has had a lasting impact on their exercise levels, fitness, and well-being.
Přehled studie
Postavení
Intervence / Léčba
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Sophia Khan, MbChB MD(Res)
- Telefonní číslo: =447557356755
- E-mail: sophia.khan@alderhey.nhs.uk
Studijní záloha kontaktů
- Jméno: Lora Capobianco, PhD., CPsychol
- E-mail: lora.capobianco@manchester.ac.uk
Studijní místa
-
-
-
Liverpool, Spojené království
- Nábor
- Alder Hey Children's Hospital
-
Kontakt:
- Becky Taylor
- Telefonní číslo: +441512525715
- E-mail: becky.taylor@alderhey.nhs.uk
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Undergoing screening for HCM due to a family history or gene-positive
- Aged 10 to 18 years (inclusive)
- Known to the inherited cardiac conditions clinic at Alder Hey Children's Hospital
- Normal cardiac function
- Able to complete an exercise log weekly with support from carers
- Child or carer able to participate in telephone follow-up
Exclusion Criteria:
- Moderate to severe co-morbidities, including neuromuscular and respiratory illness and conditions affecting mobility
- Learning difficulties precluding exercise participation
- Phenotype of HCM
- History of exercise-induced arrhythmia and/or syncope
- History of unexplained syncope
- Patients with an implantable cardiac defibrillator (ICD)
- Family History of sudden cardiac death in first-degree relative
- Child or carer unable to comply with telephone follow-up
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Jiný
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Exercise Prescription Intervention
|
After a thorough clinical assessment, an Individualised Exercise Prescription (IEP) will be provided by a specialised physiotherapist. The physiotherapy team, who will complete a retrospective baseline exercise log from the preceding week with the participant . The physiotherapist will then perform a sit-to-stand test, a hamstring flexibility test, and an ultrasound of the quadriceps on the participant. The participant will also complete a standardised quality-of-life questionnaire. After this, the physiotherapy team will provide the participant with an IEP for them to follow at home. This EP will be supervised by parents or guardians, based on the exercise log and baseline test results, and will vary in intensity and length of exercise to be achievable. The IEP will be a 6-month programme with regular monthly contact with the study team to monitor progress and then a further 12-month follow-up visit. Contact will be either face to face appointments or telephone calls. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Recruitment Rate (Feasibility and Acceptability) of IEP
Časové okno: Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
Feasibility will be assessed using recruitment rate (i.e., number of patients consented and number of patients declined the study).
|
Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Pediatric Quality of Life (PedsQoL)
Časové okno: Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
The PedsQol is a 23 item measures of health related quality of life, and includes four subscales: physical, emotional, social and school functioning. The questionnaire is commonly used in paediatric cardiology. The PedsQol will be completed by CYP. The items are scores from 0 (Never) to 4 (Almost always). Total scores range from 0-100, with higher scores indicating better quality of life. |
Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
|
Improvement in the participant's cardiovascular fitness.
Časové okno: Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
Cardiovascular fitness assessed by cardiopulmonary exercise test.
A cycle CPET using the Godfrey Protocol will be conducted.
Standard CPET data will be reported including VO2, V02 peak, Heart Rate, Blood Pressure.
|
Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
|
Hamstring Flexibility (Length of reach in cm)
Časové okno: Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
A passive knee extension test (supine).
The hip is stabilised at 90°, and the knee is extended to the first stretch sensation.
The popliteal angle is measured via goniometer (mean of three readings per leg).
|
Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
|
Sit to Stand Test (Total number of repetitions)
Časové okno: Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
Participants stand from a chair (placed against a wall) to full extension and sit back down as many times as possible in 60 seconds without using arms.
HR and SpO2 are recorded pre- and post-test.
|
Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
|
Muscle Morphology (Quadriceps femoris)
Časové okno: Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
The widest portion of the thigh (measured from the superior patellar border).
QF anterior thickness is the sum of Vastus Intermedius (Vi) and Rectus Femoris (RF) thicknesses.
Four measurements (two transverse, two longitudinal) are averaged.
RF cross-sectional area is also recorded.
|
Date of Baseline Assessment, 6 month follow up (post-treatment), and 12 month follow up.
|
|
Demographics Questionnaire
Časové okno: Baseline, 6 month follow up (post treatment), and 12 months follow up.
|
The demographics questionnaire will collect variables such as participants age, sex, weight, height, type of heart problems, and ethnicity
|
Baseline, 6 month follow up (post treatment), and 12 months follow up.
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Echocardiography
Časové okno: Baseline
|
Performed to confirm phenotype-negative status.
If not completed within the previous 3 months, these are conducted at Visit 0.
|
Baseline
|
|
Electrocardiogram (ECG)
Časové okno: Baseline
|
Performed to confirm normal sinus rhythm with normal voltages and repolarisation.
If not completed within the previous 3 months, these are conducted at Visit 0.
|
Baseline
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- IRAS355645
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Exercise Prescription
-
Beijing Tiantan HospitalThe First Hospital of Jilin University; Dongzhimen Hospital, Beijing; Huairou... a další spolupracovníciZatím nenabírámeMozková amyloidní angiopatieČína
-
Hospices Civils de LyonDokončeno
-
The University of Texas Health Science Center,...American Heart AssociationNáborNutriční deficit v těhotenstvíSpojené státy
-
Pavol Jozef Safarik UniversityUniversity of GroningenStaženoKardiovaskulární chorobySlovensko
-
University of Dublin, Trinity CollegeDokončeno
-
Kingston Health Sciences CentreCanadian Institutes of Health Research (CIHR)DokončenoChronická bolestKanada
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA)DokončenoUžívání opioidůSpojené státy
-
Istanbul Medipol University HospitalDokončeno
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Aktivní, ne náborHarm Reduction | Předávkování opioidy | Předepisování opioidů | Zneužívání lékůSpojené státy